Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.9%. By the end of trading, Alexion Pharmaceuticals fell $1.54 (-1.4%) to $107.76 on light volume. Throughout the day, 457,470 shares of Alexion Pharmaceuticals exchanged hands as compared to its average daily volume of 1,578,300 shares. The stock ranged in price between $107.29-$109.99 after having opened the day at $109.67 as compared to the previous trading day's close of $109.30. Other companies within the Health Care sector that declined today were:
), down 12.4%,
), down 12.0%,
), down 11.7% and
), down 10.4%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of life-transforming therapeutic products. Alexion Pharmaceuticals has a market cap of $21.0 billion and is part of the drugs industry. Shares are up 14.7% year to date as of the close of trading on Thursday. Currently there are 15 analysts that rate Alexion Pharmaceuticals a buy, no analysts rate it a sell, and 4 rate it a hold.
TheStreet Ratings rates
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.
- You can view the full Alexion Pharmaceuticals Ratings Report.
On the positive front,
), up 38.3%,
), up 21.7%,
), up 15.9% and
), up 15.9%.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.